SciELO - Scientific Electronic Library Online

 
vol.89 número11Cambios morfológicos en las placentas de pacientes con preeclampsia o restricción del crecimiento intrauterino e interpretación de los desenlaces perinatalesIntoxicación por monóxido de carbono en una embarazada: reporte de caso índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

Artigo

Indicadores

Links relacionados

  • Não possue artigos similaresSimilares em SciELO

Compartilhar


Ginecología y obstetricia de México

versão impressa ISSN 0300-9041

Resumo

RODRIGUEZ SANCHEZ-REYMAN, Julia et al. Ovarian carcinosarcoma in a perimenopausal woman. Ginecol. obstet. Méx. [online]. 2021, vol.89, n.11, pp.884-890.  Epub 23-Maio-2022. ISSN 0300-9041.  https://doi.org/10.24245/gom.v89i11.5207.

BACKGROUND:

Ovarian carcinosarcoma, or mixed Müllerian tumor, is a rare neoplasm that represents about 1 to 4% of epithelial ovarian carcinomas. Its histology combines sarcomatous and carcinomatous components.

CLINICAL CASE:

55-year-old female patient with a diagnosis of ovarian carcinosarcoma. She consulted due to irregular uterine bleeding and abdominal pain. Transvaginal ultrasound showed a solid and heterogeneous adnexal formation measuring 11.95 x 10.6 cm, with Doppler uptake. The study was expanded with an abdominopelvic and chest computed axial tomography (CT) scan in which a tumor was observed on the left side measuring 18 x 13 cm. Tumor markers were reported elevated: CEA 10.60, CA 125 91.3 and CA19.9 153 U/mL, with HE-4 protein 86.8 pmol/L, slightly decreased. Exploratory laparotomy was completed with R0 surgery. Chemotherapy with paclitaxel-carboplatin was indicated. The definitive histological study reported the existence of a solid-cystic tumor, compatible with a carcinosarcoma in the left ovary, with extensive peritoneal dissemination. Three months after surgery, the patient continued without signs of recurrence.

CONCLUSIONS:

Carcinosarcoma is a rare but very aggressive gynecologic tumor; because of its exceptional finding no treatment criteria are yet available. It is crucial to encourage future research on prognostic factors and biomarkers and to develop treatments targeted to the molecular characteristics of each patient.

Palavras-chave : Ovarian carcinosarcoma; Epithelial ovarian carcinoma; Sarcomatous; Irregular uterine bleeding; Abdominal pain; Tumor markers; Exploratory laparotomy.

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )